Filing Details
IOVANCE BIOTHERAPEUTICS, INC. (NASDAQ:IOVA) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event.
8k filedNASDAQ:IOVA
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Reports Material Event to SEC
Filing Details IOVANCE BIOTHERAPEUTICS, INC. (NASDAQ:IOVA) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event. Market…
Market Context
IOVANCE BIOTHERAPEUTICS, INC.'s stock currently trades at $4.31 with a market capitalization of $744.6M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for IOVANCE BIOTHERAPEUTICS, INC.'s stock.
All SEC filings for IOVANCE BIOTHERAPEUTICS, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View IOVA Stock Page
Frequently Asked Questions
Where can I read IOVA's SEC filings?
Browse all filings on our IOVA SEC filings page.
What types of SEC filings does IOVANCE BIOTHERAPEUTICS, INC. file?
Public companies like IOVANCE BIOTHERAPEUTICS, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.